Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis
Crossref DOI link: https://doi.org/10.1038/s41598-019-44864-2
Published Online: 2019-07-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nelson, Kirbylee K.
Schattner, Mark A.
Mendelsohn, Robin B.
Text and Data Mining valid from 2019-07-03
Version of Record valid from 2019-07-03
Article History
Received: 23 October 2018
Accepted: 28 April 2019
First Online: 3 July 2019
Competing Interests
: The authors declare no competing interests.